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Background: The mucus layer covering the human intestinal epithelium forms a dynamic surface for host-microbial
interactions. In addition to the environmental factors affecting the intestinal equilibrium, such as diet, it is well
established that the microbiota composition is individually driven, but the host factors determining the
composition have remained unresolved.
Results: In this study, we show that ABO blood group is involved in differences in relative proportion and overall
profiles of intestinal microbiota. Specifically, the microbiota from the individuals harbouring the B antigen (secretor B and
AB) differed from the non-B antigen groups and also showed higher diversity of the Eubacterium rectale-Clostridium
coccoides (EREC) and Clostridium leptum (CLEPT) -groups in comparison with other blood groups.
Conclusions: Our novel finding indicates that the ABO blood group is one of the genetically determined host factors
modulating the composition of the human intestinal microbiota, thus enabling new applications in the field of
personalized nutrition and medicine.Background
The human gastrointestinal tract (GIT) comprises an
extremely dense and diverse microbiota. The GIT of an
adult may harbour even 2 kg of bacterial biomass repre-
senting over 1000 bacterial species, of which majority
can not be cultivated [1]. This microbiota in the large
intestine is mainly composed of Firmicutes and Bacteroi-
detes phyla making up respectively over 75% and 16% of
total microbes in the GIT [1]. The human intestinal
microbiota has recently been shown to cluster into three
distinct enterotypes [2] and of these enterotypes, Bacter-
oides and Prevotella dominated microbial communities
have been reported to be associated with long-term diets
[3]. Previously, twin studies have suggested a role for the
host genotype in determining the microbiota composition
[4], but the genetic host factors potentially affecting the
gastrointestinal microbiota composition are unknown to a
large extent.
The mucosal layer covering our gut epithelium has an
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distribution, and reproduction in any mediumalso enables contacts between intestinal microbiota and
the host [1,5]. The microbial biomass in the large intes-
tine is mainly residing in the lumen and the mucosa-
associated population differs from the lumen population
[1]. There is a continuous interplay between the mucus
secretion and degradation by bacteria as bacterial meta-
bolites have been shown to act as signalling molecules
modulating the mucus synthesis [6]. The mucus is
mainly composed of mucins, large glycoproteins con-
taining a protein core and attached oligosaccharides [7].
We recently observed a significant association between
the blood group secretor status (encoded by fucosyl-
transferase-2, FUT2, gene) and the intestinal bifidobac-
teria composition [8]. The secretor status defines the
expression of the ABO blood group antigens in the
mucus of secretor individuals (80% of Western popula-
tion). These antigens are expressed in the intestinal mu-
cosal layer, and act as binding sites or carbon sources for
the intestinal microbes, thereby providing a host-specific
genetic agent affecting the microbiota composition
[9,10].
Some microbes e.g. Helicobacter pylori and some
other pathogenic bacteria and viruses have been shown
to use ABO blood group antigens as adhesion receptorsntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Lactobacillus spp., which tend to adhere in a strain-
specific manner [12]. Besides adhesion sites, secreted
mucus provides endogenous substrate for bacteria. The
mucus may be a major nutrient source in situations,
where carbohydrates originating elsewhere are limited
[13]. Some microbes e.g. bifidobacteria and Bacteroides
thetaiotaomicron are also able to specifically utilize
blood group antigens, e.g. the glycan structures of ABO
antigens [14,15].
In the present study, we aimed to evaluate, whether
there is a correlation between ABO blood group pheno-
type and relative proportions of the most abundant
groups of healthy human gastrointestinal microbiota.
We used several well characterised molecular and bio-
chemical methods in order to address the hypothesis in
deep detail. To our knowledge, this is the first study
comparing the effects of human blood group phenotype
with the intestinal microbiota composition.
Results & discussion
In this study, we hypothesized that the ABO blood
group antigens, which are expressed on the intestinal
mucosa of secretor individuals [16,17] determine the
gastrointestinal microbiota composition in healthy indi-
viduals. We recruited 79 healthy adult volunteers living
in Southern Finland to test this hypothesis. The pool of
study subjects was narrowed by excluding individuals
with non-secretor phenotype and the fecal and blood
samples of the final study pool of 64 volunteers was ana-
lysed by applying several molecular techniques (demo-
graphics in Table 1). The male/female ratio in the final
study pool was 7/57 (similar in each of the ABO blood
groups), but as we were interested in the differencesTable 1 Demographics of the study population
Blood group
A B AB O
Female 17 (85%) 11 (92%) 12 (92%) 17 (89%)
Male 3 (15%) 1 (8%) 1 (8%) 2 (11%)
Total* 20 12 13 19
Rh+ 19 (95%) 10 (83%) 12 (92%) 19 (100%)
Rh- 1 (5%) 2 (17%) 1 (8%) 0
Average age** 44 (33–58) 43 (31–57) 48 (39–58) 46 (31–61)
79 persons were recruited to the study. Exclusion criteria in the recruitment
were: diagnosed gastrointestinal disorders, antibiotic treatment in past two
months, pregnancy, problems in blood coagulation, vegetarian diet and age
below 18 or over 61. In addition, non-secretor persons (15) were excluded,
thus the final study pool was 64 persons. Average age is presented together
with the age range of each ABO blood group. Rh +/− states the presence/
absence of the Rhesus-factor in blood.
*No statistical difference (P> 0.95) was detected in participant numbers
between blood groups.
** No statistical difference (P> 0.45) was detected in participant age
distribution between blood groups.between the different ABO blood group antigens com-
mon to both genders and GIT microbiota, the gender
imbalance was not considered to affect the results. Due
to small number of subjects in each ABO blood group,
no statistical methods were used to define the number
of individuals in each of the study groups.
The %G+C profiling that was performed to 46 fecal sam-
ples high enough genomic-DNA yield (>20 μg), revealed
ABO blood group related differences in the overall faecal
microbiota profiles (Figure 1). The longitudinal shifts in the
profile peaks suggested large differences in the microbiota
composition, particularly evident in the mid-%G + C area
(35–45; representing the majority of faecal microbes) and
the high %G + C area (55–59; the area dominated by Acti-
nobacteria). In the overall microbiota profiles from blood
group A individuals, a shift towards higher %G+C
microbes was observed, and the profiles from blood group
B individuals showed the highest microbial density in the
mid-%G + C area. In the high %G + C range, the highest
peak was observed in the blood groups O and AB. The
observed differences in the %G + C profiles were found to
be statistically significant (Table 2). The short chain fatty
acid and lactic acid analysis or total bacterial numbers
determined by flow cytometry did not differ between the
ABO blood groups (data not shown).
A denaturing gradient gel electrophoresis (PCR-
DGGE) analysis was performed to determine which
major bacterial groups were responsible for the differ-
ences detected in the overall microbiota profile using %
G+C profiling. The redundancy analysis (RDA) of the
PCR-DGGE profiles revealed that ABO blood groups are
statistically significantly associated with the intestinal
microbiota composition, as determined by PCR-DGGE
primers targeting all bacteria (UNIV: p = 0.015) and the
Eubacterium rectale – Clostridium coccoides group
(EREC: p = 0.032) (Figure 2). The microbiota from sub-
jects harbouring the B antigen (B and AB) differed sig-
nificantly from non-B antigen blood groups (A and O)
in regard to the levels of the UNIV (p = 0.005), the EREC
(p = 0.005) and the Clostridium leptum (CLEPT)
(p = 0.01) bacterial groups. In addition to the distinct
clustering of the microbiota profiles, PCR-DGGE ana-
lysis revealed significant ABO blood group related differ-
ences in the species diversity within the EREC and the
CLEPT groups, with blood groups B and AB showing
the highest, and blood group O the lowest, diversity
(Figure 3). These findings suggest that the mucosal ex-
pression of blood group antigen B, in particular, appears
to affect the dominant microbiota composition. The as-
sociation of blood group B antigen is also reflected in
the %G+C-range of 30–44.
The association we found between the ABO blood
groups, especially the presence of the group B antigen, is
strengthened by comparable results having been obtained
Figure 1 %G+C-profile-data grouped by ABO blood groups. Averaged %G+C-profiles grouped by ABO blood groups revealing a difference
in the overall microbial profile between ABO blood groups. Each line represents the average of %G+C-data points of individuals with different
ABO blood groups. Line colours for each ABO group are as follows: A = red, B = blue, AB = green and O = black.
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quantitative PCR-DGGE method identified specific asso-
ciations within the major intestinal bacterial groups, and
the qualitative %G+C profiling supported these findings
and demonstrated that the microbial differences asso-
ciated with the blood groups are large enough to affect the
relative quantities of the major bacterial groups, thus
impacting the overall microbial profile. We speculate that
the statistically significant differences in these important
bacterial groups may indeed have in vivo relevance. Be-
sides adhesion sites, mucus provides endogenousTable 2 Statistical significances between 5%G+C-fractionated
5% increment A vs. O A vs AB A
20-24 0,0002 0,0020 0,0
25-29 0,0396 0,0001 0,0
30-34 0,0064 0,0003 0,0
35-39 0,0036 0,0036 0,0
40-44 0,0887 0,0340 0,1
45-49 0,0001 0,0004 0,0
50-54 0,0370 0,0085 0,1
55-59 0,0015 0,0055 0,1
60-64 0,3104 0,0091 0,0
65-69 0,0112 0,0769 0,1
70-74 0,0096 0,2943 0,3
Statistical significances between indicated groups were tested using Student's t-tessubstrates for bacteria in the intestine, especially in the
colon, where the easily degradable carbohydrates have
already been consumed [13,18,19]. Our present finding on
the association of the blood group and the group B anti-
gen with the composition of intestinal microbiota may
partly help to explain the recent discovery of the three
enterotypes of human intestinal microbiota [2]. Interest-
ingly, an early study supports our result on the importance
of the blood group B antigen: in 1976, Hoskins & Bould-
ing published their findings showing that blood group B
subjects had more B-antigen degrading glycosidasessamples grouped and averaged by ABO blood group
vs B O vs B O vs AB AB vs B
605 0,0012 0,0004 0,0021
194 0,0004 0,0015 0,1365
0001 0,0002 0,0356 0,2061
0045 0,0129 0,0576 0,1745
827 0,0106 0,0150 0,0003
010 0,0019 0,0039 0,0001
061 0,00001 0,0058 0,0004
444 0,0173 0,0171 0,0190
016 0,0016 0,0016 0,0051
741 0,2190 0,0772 0,0364
287 0,0104 0,0068 0,3402
t; highly significant values (p< 0.005) are marked in bold.
Figure 2 (See legend on next page.)
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Figure 2 RDA-visualization of PCR-DGGE profile similarities. RDA visualization of microbiota profile similarities and ABO blood group types,
revealing a clustering of the samples. Each dot represents a single individual and diamonds mark the calculated data centre points of the
corresponding blood groups. P-value marks the statistical significance of the difference between blood group centres, computed with ANOVA-
like permutation test from PCR-DGGE intensities grouped by ABO blood group (A) or by the presence of B-antigen (B). Dot colours for the ABO
blood groups are as follows: A = red, B = blue, AB = green and O=black and for the B-antigen= blue and non-B antigen red, respectively. UNIV
represent the PCR-DGGE obtained with the universal eubacterial primers (dominant bacteria), EREC with the Eubacterium rectale – Clostridium
coccoides primers and CLEPT with the Clostridium leptum primers. The RDA analysis shows clustering of samples according to ABO blood groups,
especially according to the presence of the B antigen in the dominant and EREC group microbiota.
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subjects [9].
To further explore the ABO blood group and ABO
blood group antigen related associations in the intestinal
microbiota, we continued microbiota profiling by target-
ing selected, less dominant bacterial groups colonising
the intestine. Large individual variation in the diversity
of the Bacteroides population was observed by BFRA
DGGE. No ABO blood group related differences in the
diversity or clustering of the Bacteroides population was
observed (Figure 4) even though Bacteroides spp. is
known to be capable of utilising a variety of host-derived
glycans, including blood group glycans [14]. We never-
theless observed certain ABO blood group associated
differences in the detection frequency of some of the
band positions in the BFRA DGGE (Table 3), suggesting
the existence of species or strain level differences in the
Bacteroides population between the ABO blood groups.
Since we observed ABO blood group related differences
in the high GC area of the %G+C profile, we studied
further the abundance of the genus Bifidobacterium, a
typical component of the adult human intestinal micro-
biota, composing roughly 6% of the total microbiota
[20]. The total average numbers of the genus Bifidobac-
terium in different ABO blood groups (Figure 5) varied
highly between the samples, and ABO blood group asso-
ciated differences were not detected by the qPCR, when
the results of blood groups were compared with
ANOVA. In PCR-DGGE analysis blood group O subjects
were observed to have higher diversity or clustering
compared to blood group AB subjects (Figure 6). As a
culture-independent, yet primer-dependent, methods
qPCR and PCR-DGGE rely on specificity and sensitivity of
primers bacteria and %G+C-profiling is a solely culture-
and primer-independent method allowing the detection of
the most abundant microbial groups present in the sample
regardless of prior knowledge of the groups, the differences
between the bifidobacteria related results might be caused
by both %G+C-detection of other Actinobacteria than
Bifidobacterium, e.g. Collinsella species (second most
abundant phylotype reported in Actinobacteria [21]), and
qPCR/PCR-DGGE not detecting all possible bifidobacteria.
Furthermore, the sudden disappearance of B. bifidum fromAB-persons may be due to that B. bifidum is rather infre-
quently detected Bifidobacterium species in Caucasian
adults [22] and thus the small number of study subjects
may have influenced the result.
In our study, we did not observe any ABO blood
group associated differences in the diversity or cluster-
ing of the Lactobacillus population (Figure 6). However,
the differences in the detection frequency of several
Lactobacillus spp. genotypes (band positions: Table 3)
suggest the existence of specific ABO blood group
associated Lactobacillus spp. species or strains as
described by Uchida et al. [12].
The biochemical structures of the ABO blood group gly-
can antigens present in both platelets and secretory intes-
tinal organs, including mucosal layer, were published
already in 1952 [23]. Krusius et al. reported that ABO
blood group antigens are present on erythrocyte glycopro-
teins as polyglycosyl chains [24]. Studies focusing on the
expression of glycans in the human intestine have identi-
fied the presence of ABO type 1 glycans in the mucosal
layer covering human orogastrointestinal tract and have
shown that the fucosylated glycans, including ABO blood
group glycan antigens, are detected less abundantly to-
wards the distal parts of the intestine [16,17]. The ABO
blood group glycans are reported to be exported to the
mucus layer from goblet cells residing in the crypts of the
small intestine [17]. Secretor- and Lewis-genes control the
secretion of ABO blood group antigens to all bodily liquid
secretions, such as tears, milk, saliva and gastrointestinal
mucus, and to secreting organs, such as pancreas and liver
(reviewed by Henry [25]). Already in 1960's and 1970's,
correlations between human ABO blood group phenotype
and susceptibility to develop several diseases were broadly
postulated based on data from large epidemiological stud-
ies carried out around the world. Since the development
of the high throughput genomic analysis tool, research has
been increasingly focused on revealing correlations be-
tween individual genotypes and disease. Indeed, highly se-
lective associations of ABO and Lewis blood group
antigens as adhesion receptors have been described for
common intestinal pathogen Helicobacter pylori [11],
demonstrating the existence of genotype-specific bacterial
adhesion on blood group glycan structures. However, the
Figure 3 ABO blood group related differences in the
microbiota diversity. The Shannon Diversity index calculations of
the PCR-DGGE profiles obtained with a) universal eubacterial (UNIV)
primers, b) Eubacterium rectale – Clostridium coccoides (EREC) primers
and c) Clostridium leptum (CLEPT) primers. Columns are
averaged± SD values of the corresponding ABO blood groups.
Statistically significant differences BASED on ANOVA tests between
ABO blood groups are marked with diagonal bars and with the
corresponding p-value.
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and their effects on the overall composition of the intes-
tinal microbiota have been lacking.Conclusions
Here, we demonstrate that Finnish individuals with differ-
ent ABO blood group status have differences in the reper-
toire and diversity of microbes of their intestinal bacterial
population. In particular, the composition of the micro-
biota in individuals with B-antigen is differently clustered
from that in non-B-individuals. We have also recently
demonstrated differences in the intestinal microbiota
composition associated with the host blood group secre-
tor/non-secretor status [8]. These findings may at least
partially explain the recent discoveries by Arumugam
et al. [2] reporting clustering of human intestinal micro-
biota into three different enterotypes and by Wu et al. [3]
correlating long-term diets to the enterotypes, as the host-
microbe interaction in form of ABO blood group antigen
dependent microbiota has not been taken into account in
either of these studies. However, as all our study subjects
were Caucasians from Finland, genetic variation being
thus small between the subjects, the extrapolation of the
results to international context would require additional
samples from genetically and nutritionally differing areas.
As our study provides a link between the host genetic fac-
tors and the clustering of the intestinal microbiota in this
Finnish cohort, it also warrants further investigations with
high-throughput techniques of microbiota analysis to
evaluate whether the specific species/OTUs responsible
for the microbiota differences can be found, thus poten-
tially enabling new applications in the field of personalized
nutrition and medicine.Methods
Subjects and samples
One faecal and one blood sample was collected from 79
healthy Caucasian donors from Southern Finland for the
analysis. Pregnant subjects and subjects with diagnosed
GIT disorders, regular GIT complaints or antibiotic medi-
cation within two months prior to the faecal sampling were
excluded from the study. All subjects were eating mixed
diets and subjects on vegetarian diets were excluded. The
nutritional intake was not controlled, except for not allow-
ing drastic dietary changes or the habitual use of probiotic
supplements/probiotic-supplemented food products and
alcohol prior to the faecal sampling. Body mass index of the
Figure 4 RDA visualization of microbiota profile similarities and
ABO blood group types. Each dot represents a single individual,
taking into account all individual intensities measured in each
PCR-DGGE group. Diamonds mark the calculated data centre points
of the corresponding blood groups. P-value marks the statistical
significance of the differences between the blood groups from
ANOVA-like permutation test. Dot colours for the ABO blood groups
are as follows: A= red, B=blue, AB=green and O=black. a) PCR-DGGE
with Bacteroides fragilis (BFRA) primers, b) Lactobacillus (LACT) primers
and c) Bifidobacterium (BIFI).
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ethical committee of the Helsinki University Hospital and
all subjects signed a written informed consent. Faecal
samples were collected in containers with anaerobic atmos-
phere generators, samples were homogenized by mixing
and distributed to 1 g aliquots in an anaerobic cabinet and
aliquots were frozen at −70 °C within 5 hour from
defecation.
The fecal aliquots were processed as described in [26] to
isolate the bacterial genomic DNA. Briefly, 1 g of feces was
washed to separate the eukaryotic cells from the microbial
cells. The collected bacterial mass was pelleted with high
speed centrifugation, the pellet was suspended to freeze-
thaw buffer and the solution was frozen to −70 °C. A sam-
ple for flow cytometry was drawn at this stage. The sample
for DNA extraction went through five freeze-thaw-cycles,
after which enzymatic (lysozyme, proteinase K), chemical
(sodium dodecyl sulphate) and bead beating techniques
were utilized to break down the cells and chloroform-isoa-
mylalcohol-extraction to isolate the bacterial genomic
DNA from cell debris. The bacterial genomic DNA was
purified using an isolation kit (Blood & Cell Culture DNA
Midi Kit Cat no. 13343; Qiagen Inc., USA) according to
manufacturer’s instructions. The isolated DNA was diluted
to TE-buffer and the DNA concentration was determined
using NanoDrop (Thermo-Fisher Scientific, USA). Quality
of the DNA was assessed by measuring the ratio 260/
280 nm, samples having ratio between 1.7-2.0 and total
concentration higher than 20 μg/g were accepted.
Blood samples were analysed for the presence ABO
and RH blood group with a haemagglutination assay
using Olympus PK 7300 according to standard blood
group typing practice. The secretor status of the indivi-
duals was determined based on the presence of Lewis a
and Lewis b antigens by using monoclonal antisera
(Sanquin, the Netherlands) and by genotyping of the
FUT2 gene as described in [8]. Volunteers with non-
secretor phenotype (n = 15) were dismissed from further
studies, resulting in a study group of 64 individuals (57
female and 7 male; age range 31–61 years). The demo-
graphic and blood group distribution of the volunteers
is presented in Table 1).
Table 3 Association of the bacterial PCR-DGGE genotypes with the ABO blood groups
Detection frequency of the DGGE genotype**
DGGE genotype*, number of genotypes B+AB vs. O+A (p-value) A +AB vs. O+B (p-value) O vs. A +AB+B (p-value)
UNIV, 18.0%, 9 35% vs 3% (0.002) 6% vs. 22% 5% vs. 35%
UNIV, 31.4%, 21 48% vs. 23% (0.014) 38% vs. 28% 42% vs. 11%
UNIV, 32.2%, 8 30% vs. 3% (0.004) 13% vs. 13% 5% vs. 16%
UNIV, 33.8%, 56 74% vs. 95% (0.004) 84% vs. 91% 100% vs. 82%
UNIV, 39.0%, 9 17% vs. 13% 25% vs. 3% (0.026) 5% vs. 18%
UNIV, 42.2%, 9 30% vs. 5% (0.022) 16% vs. 13% 0% vs. 20%
UNIV, 47.0%, 7 22% vs. 5% (0.012) 9% vs. 13% 5% vs. 13%
UNIV, 49.4%, 8 0% vs. 20% (0.018) 13% vs. 13% 21% vs. 9%
UNIV, 58.8%, 11 30% vs. 8% (0.002) 16% vs. 19% 11% vs. 20%
UNIV, 61.1%, 17 17% vs. 0% (0.020) 9% vs. 3% 0% vs. 9%
LACT, 9.0%, 11 16% vs. 10% (0.092) 16% vs. 19% 11% vs. 20%
LACT, 14.1%, 15 26% vs. 18% 25% vs. 22% 5% vs. 31% (0.028)
LACT, 15.4%, 5 17% vs. 3 (0.072) 9% vs. 6% 0 vs. 11%
LACT, 66.3%, 10 17% vs. 15% 25% vs. 6% (0.082) 5% vs. 20%
LACT, 74.2%, 3 0% vs. 8% 0% vs. 9% 6% vs. 0% (0.023)
LACT, 83.1%, 4 9% vs. 0% 0% vs. 6% 0% vs. 4%
LACT, 84.7%, 40 65% vs. 59% 59% vs. 66% 74% vs. 58%
LACT, 86.6%, 3 0% vs. 8% 0% vs. 9% 16% vs. 0% (0.023)
LACT, 92.3%, 8 4% vs. 18% 6% vs. 19% 32% vs. 4% (0.007)
EREC 4.8%, n = 13 22% vs. 20% 34% vs. 6% (0.011) 5% vs. 27%
EREC 35.3%, 8 26% vs. 5% (0.048) 16% vs. 9% 5% vs. 16%
EREC, 39.7%, 9 26% vs. 5% (0.022) 16% vs. 13% 0% vs. 20% (0.048)
EREC, 46.9%, 19 52% vs. 18% (0.004) 31% vs. 28% 11% vs. 38% (0.004)
EREC, 50.9%, 34 70% vs. 43% (0.021) 53% vs. 53% 37% vs. 60%
EREC, 61.1%, 18 43% vs. 20% (0.044) 22% vs. 34% 32% vs. 27%
EREC, 73.9%, 28 61% vs. 35% (0.043) 44% vs. 44% 37% vs. 47%
CLEPT, 11.9%, 31 22% vs. 63% (0.002) 47% vs. 50% 63% vs. 42%
CLEPT, 15.4%, 8 22% vs. 8% (0.048) 6% vs. 19% 5% vs. 16%
CLEPT, 16.0%, 6 26% vs. 0% (0.002) 16% vs. 3% 0% vs. 13%
CLEPT, 20.5%, 9 26% vs.8% (0.022) 13% vs. 16% 5% vs. 18%
CLEPT, 38.8%, 8 22% vs. 8% (0.048) 16% vs. 8% 0% vs. 18%
CLEPT, 52.1%, 8 4% vs. 18% 9% vs. 16% 26% vs. 7% (0.044)
CLEPT, 67.9%, 12 30% vs. 13% (0.048) 13% vs. 25% 11% vs. 22%
CLEPT, 84.0%, 7 0% vs. 18% (0.037) 6% vs. 16% 26% vs. 4% (0.021)
BFRA, 5.0%, 5 21% vs. 0% (0.008) 6% vs. 9% 0% vs. 11%
BFRA, 9.9%, 10 21% vs. 13% 26% vs. 6% (0.043) 5% vs. 20%
BFRA, 21.5%, 9 25% vs. 10% (0.023) 6% vs. 22% 11% vs. 16%
BFRA, 36.8%, 7 0% vs. 18% (0.036) 10% vs. 13% 21% vs. 7%
BFRA, 62.8%, 5 0% vs. 13% 3% vs. 13% 21% vs. 2% (0.026)
BIFI, 26.6%, 40 59% vs. 77% 62% vs. 79% 94% vs. 61% (0.022)
*The DGGE analysis was performed by applying universal bacterial primers (UNIV) and specific primers for the lactic acid bacteria (LACT), Eubacterium
rectale – Clostridium coccoides group (EREC), Clostridium leptum group (CLEPT), Bacteroides fragilis group (BFRA) and Bifidobacterium spp. (BIFI).
**Detection frequencies (% of samples positive) of the specified DGGE genotypes are presented. Statistical analysis: The Fisher's exact test based on band
presence/absence data. P-values for the statistically significant differences are presented in parenthesis.
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Figure 5 Abundance of bifidobacteria in ABO blood groups. a) Total bifidobacteria counts (copies/g faeces: average ± SD) by bifidobacteria
species and genus specific qPCR-analysis. b) Detection frequencies (% of samples positive) of bifidobacteria as determined with the
Bifidobacterium genus and species specific qPCR analysis.
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analysis
The genomic DNA in microbe samples was profiled using
the %G+C-profiling technique allowing the identificationof microbial clusters or subsets in samples according to
their genomic G+C contents [26]. In brief, the method is
based on the molecular weight difference between A-T
and G-C linkages in DNA double helix, achieved by A-T
Figure 6 ABO blood group related differences in the
microbiota diversity. The Shannon Diversity index calculations of
the PCR-DGGE profiles obtained with a) Bacteroides fragilis group
(BFRA) primers, b) Lactobacillus (LACT) primers and c) Bifidobacterium
(BIFI) primers. Columns are averaged± SD values of the
corresponding ABO blood groups.
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DNA strands with different AT/GC ratios by ultracentri-
fugation, which are then visualized using UV light. Sam-
ples with a low genomic DNA yield (<20 μg/g fecal
material) were excluded from the analysis and the %
G+C-profiling was performed for 46 samples (14 repre-
senting A, 16 O, 8 B and 8 AB blood group). The same
subset of faecal samples was further analyzed using SCFA
and flow cytometric analyses as follows. The analysis ofSCFA and lactic acid was essentially performed as
described by Fava et al. [27], using gas chromatography to
establish the concentration of SCFAs acetic, propionic,
butyric, isobutyric, valeric, isovaleric and 2-methylbutyric
acids, as well as lactic acid. The total numbers of bacteria
in the samples were determined using a flow cytometric
FACSCalibur system (BD Biosciences, San Jose, CA, USA)
as previously described in [28]. For the method, the sam-
ples were fixed with 37% formaldehyde to obtain final
concentration of 4% and the samples were stained with a
fluorescent nucleic acid binding dye, SYTO 24 (Molecular
Probes, The Netherlands).PCR-DGGE analysis
An extended sample set consisting of faecal samples from
21 blood group A, 19 O, 13 B and 11 AB individuals was
analyzed using PCR-DGGE targeting the dominant eubac-
teria (UNIV) and specific bacterial groups, namely Eubac-
terium rectale – Clostridium coccoides group (EREC);
Clostridium leptum group (CLEPT); Bacteroides fragilis
group (BFRA); Bifidobacterium spp. (BIF) and Lactobacil-
lus spp. (LACT). The PCR-DGGE analysis was performed
as described by [8], with bacterial group specific modifica-
tions. Briefly, DNA from 0.3 g of faecal material was
extracted using the FASTDNAW SPIN KIT FOR SOIL
(Qbiogene) and the quality of the DNA was determined
using NanoDrop as described above. Partial eubacterial
16 S rRNA gene was amplified using PCR with universal
or group-specific primers: UNIV, U-968-F-GC and U-
1401-R [29], EREC, CcocF and CcocR-GC [30], CLEPT,
Clept-F and CleptR3-GC [30], BFRA, BfraF and BfraR-GC
[30], BIF, Bif164F and Bif662R-GC [30] and LACT, Lac1
and Lac2-GC [31]. Amplified PCR fragments were sepa-
rated in 8% DGGE gel with denaturing gradient ranging
from 45% to 60%. DGGE gels were run at 70 V for
960 min in a gradient optimised for each bacterial group
(UNIV 38-60%, EREC 40-58%, CLEPT 30-53%, BFRA
30-45%, BIF 45-60% and LACT 38-55%). DGGE gels were
stained with SYBRSafe for 30 mins and documented with
SafeImager Bluelight table (Invitrogen) and AlphaImager
HP (Kodak) imaging system. Digitalised DGGE gel images
were imported to the Bionumerics-program version 5.0
(Applied Maths) for normalisation and band detection.
The bands were normalised in relation to a marker sample
specific for the said bacterial groups. Band search and
band matching were performed as implemented in the
Bionumerics. Bands and band matching were manually
checked and corrected. The principal component analysis
was calculated in the Bionumerics. The PCR-DGGE band
intensity data was analyzed with Redundancy Analysis
(RDA) [32] using ABO blood group status or presence of
B-antigen as grouping factors followed by ANOVA-like
permutation test.
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The qPCR method was applied to detect and quantify the
16 S rRNA gene copies of bacteria, bifidobacteria and four
bifidobacterial species/groups, B. bifidum, B. longum group,
B. catenulatum/pseudocatenulatum and B. adolescentis in
faecal samples [8]. In short, reaction mixture was composed
of 0.3 μM of each primer, PCR Master Mix and faecal
DNA diluted 1 ng/μl for bifidobacteria group/species-
specific primer pairs and 0.1 ng/μl for universal primers
and bifidobacteria primers. All the samples and standards
were analyzed in three replicates. The results were com-
pared to standard curves for each bacterial group of known
concentrations of the bacterial genomic DNA (from 10 ng/
μl to 0.0001 ng/μl) and calculated as copies/g wet feces and
the detection threshold was set to 107 copies/g. The ampli-
fication efficiencies were from 93% to 98% for all the other
qPCR primer pairs except for B. bifidum specific primers,
in which amplification efficiency varied from 80% to 92%
and for B. catenulatum/pseudocatenulatum, in which effi-
ciency varied from 87% to 91%.
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